P

POINT Biopharma

116 employees

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Radiopharmaceutical
Health Care
Therapeutics
Oncology
Radioligand
Biopharma
Cancer

Date founded

2019

Funding rounds raised

Total raised

$165M

from 6 investors over 6 rounds

P

POINT Biopharma raised $165M on July 1, 2021

Investors: Suvretta Capital Management LLC, Woodline Partners LP, Farallon Capital Management, RA Capital Management, L.P., Surveyor Capital and Perceptive Advisors

FAQ